Court Discharges Ex-Drug Controller Eswara Reddy in Bribery Case
A CBI court in Delhi discharged ex-joint drugs controller S Eswara Reddy and three others in the 2022 Biocon Biologics bribery case, citing no evidence.
CDSCO
Sun Pharma Wins CDSCO Nod for Generic Oral Semaglutide Pill
Sun Pharmaceutical Industries has received approval from the Central Drugs Standard Control Organisation (CDSCO) to manufacture and market a generic […]
CDSCO Halts Sun Pharma Eye-Drop Production at Assam Plant
Regulators have stopped Sun Pharma from making and selling eye-care drugs from its Assam plant over quality system failures, with 332 recalled batches under review.
Imported Drugs Now Need 12 Months of Shelf Life Under New Rule
India now requires imported medicines to have at least 12 months of shelf life left on arrival, replacing the 60% rule; biologics and radiopharmaceuticals keep a 60% test.
India Medicine Sales Grow 12% to ₹70,180 Crore in Sept Quarter
India’s medicine sales rose 12% to ₹70,180 crore in the September quarter, a fourth straight double-digit gain led by cardiac, diabetes and cancer drugs.
CoSara Diagnostics Seeks CDSCO Nod for 30-Minute Point-of-Care TB PCR Test, Eyes India Launch Before Year-End
CoSara Diagnostics, the Indian joint venture of Co-Diagnostics and Synbiotics, has filed its point-of-care TB PCR test with CDSCO after a 676-sample Indian study showed 97.3% sensitivity and 96% specificity, with results in about 30 minutes via a mobile app.
CDSCO Asks States to Enforce Batch Testing of Raw Materials, Excipients and Finished Drugs
In a 27 October notice, DCGI Rajeev Raghuvanshi has asked state and UT drug regulators to make manufacturers test every batch of raw materials, critical excipients such as propylene glycol, glycerol and sorbitol, and finished products, and to enforce vendor qualification after inspections found lapses.
Supreme Court Raps Centre, DCGI Over Antifungal Drug Sold for Five Years on Expired Covid-Era Approvals
The Supreme Court questioned why regulators took five years to act against companies allegedly selling Liposomal Amphotericin B under lapsed Covid-era emergency permissions, and said its directions will apply across the board.
UK-India FTA to Strengthen Pharma Partnerships, Says H. E. Gareth Wynn Owen
Speaking at India Pharma Expo 2026, H. E. Gareth Wynn Owen, British Deputy High Commissioner, highlighted the transformative potential of […]
The Future of Pharma: Innovation, Self-Reliance, and Skilling as Key Pillars
India’s pharmaceutical sector is entering a transformative phase, driven by innovation, digital technologies, regulatory reforms, and a renewed focus on […]
CDSCO Expert Committee Accepts Phase IV Safety Data for Eisai’s Lenvatinib Capsules
The Subject Expert Committee (SEC) under India’s drug regulator, the Central Drugs Standard Control Organisation (CDSCO), has accepted the Phase […]
Drug Safety in India: CDSCO Crackdown, Kerala’s nPROUD Initiative, and the Fight Against Substandard Medicines
India’s pharmaceutical landscape witnessed a series of proactive measures in 2023-24, addressing critical issues like drug quality, combating spurious and […]
ENTOD Pharmaceuticals Introduces PresVu Eye Drops to Combat Presbyopia
In a groundbreaking development in the field of ophthalmology, ENTOD Pharmaceuticals has secured approval from the Central Drugs Standard Control […]
